Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

User Headshot

Cheryl Corcoran

Icahn School of Medicine, New York


Professional Bio

Cheryl Corcoran is Associate Professor and Leader in Psychosis Risk at the Icahn School of Medicine at Mount Sinai.  She is a graduate of Harvard College and Harvard Medical School and has a masters in biostatistics. Dr. Corcoran has twenty years’ experience in research on “clinical high risk” for psychosis, encompassing natural language processing (NLP), sensory processing (auditory/visual/olfactory), social cognition, neuroimaging, clinical correlates, cannabis/stress exposures, nosology, ethics/stigma, clinical trials, and services. 

Her most recent focus has been on using artificial intelligence (AI) for computational phenotyping, including analyses of the semantic and syntactic structure of language across stages of schizophrenia, including psychosis risk. She has federal NIMH grants to study both the associated neural correlates of this language impairment, and the generalizability of these deficits to cohorts worldwide. She is now expanding this use of AI to examine abnormal speech acoustics and pause behavior, and abnormal face expression across stages of schizophrenia, including risk states. 

We use cookies to ensure you get the best experience on our platform, by continuing to use this site you agree that we can save them on your device. For more information, please read our Privacy Policy